Lee Ainslie's HCA Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 3,319 shares of HCA Healthcare, Inc. (HCA) worth $1.42 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in HCA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2013, adding 1.4 M shares. Largest reduction occurred in Q1 2015, reducing 2.41 M shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's HCA Healthcare (HCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly HCA Healthcare (HCA) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +3,319 | New Buy | 3,319 | $426.74 |
| Q4 2023 | -5,022 | Sold Out | 0 | $0.00 |
| Q3 2023 | -6,255 | Reduce 55.47% | 5,022 | $245.98 |
| Q2 2023 | +11,277 | New Buy | 11,277 | $303.48 |
| Q4 2022 | -5,191 | Sold Out | 0 | $0.00 |
| Q3 2022 | -250 | Reduce 4.59% | 5,191 | $183.78 |
| Q2 2022 | +3,967 | Add 269.13% | 5,441 | $167.98 |
| Q1 2022 | +1,474 | New Buy | 1,474 | $250.34 |
| Q4 2021 | -720 | Sold Out | 0 | $0.00 |
| Q3 2021 | -112 | Reduce 13.46% | 720 | $243.06 |
| Q2 2021 | +490 | Add 143.27% | 832 | $206.73 |
| Q1 2021 | -15,980 | Reduce 97.90% | 342 | $187.13 |
| Q4 2020 | -18,808 | Reduce 53.54% | 16,322 | $164.44 |
| Q3 2020 | -28,136 | Reduce 44.47% | 35,130 | $124.68 |
| Q2 2020 | -14,316 | Reduce 18.45% | 63,266 | $97.07 |
| Q1 2020 | +52,543 | Add 209.84% | 77,582 | $89.85 |
| Q4 2019 | +5,302 | Add 26.86% | 25,039 | $147.81 |
| Q3 2019 | +19,737 | New Buy | 19,737 | $120.43 |
| Q2 2019 | -31,640 | Sold Out | 0 | $0.00 |
| Q1 2019 | +31,640 | New Buy | 31,640 | $130.37 |
| Q2 2018 | -13,570 | Sold Out | 0 | $0.00 |
| Q1 2018 | +13,570 | New Buy | 13,570 | $96.98 |
| Q4 2017 | -68,850 | Sold Out | 0 | $0.00 |
| Q3 2017 | +22,300 | Add 47.91% | 68,850 | $79.59 |
| Q2 2017 | +14,280 | Add 44.25% | 46,550 | $87.20 |
| Q1 2017 | -12,460 | Reduce 27.86% | 32,270 | $89.00 |
| Q4 2016 | +44,730 | New Buy | 44,730 | $74.02 |
| Q2 2016 | -369,220 | Sold Out | 0 | $0.00 |
| Q1 2016 | +369,220 | New Buy | 369,220 | $78.05 |
| Q2 2015 | -874,177 | Sold Out | 0 | $0.00 |
| Q1 2015 | -2.41 M | Reduce 73.39% | 874,177 | $75.23 |
| Q4 2014 | -871,690 | Reduce 20.97% | 3.29 M | $73.39 |
| Q3 2014 | -1.83 M | Reduce 30.60% | 4.16 M | $70.52 |
| Q2 2014 | +1.11 M | Add 22.84% | 5.99 M | $56.38 |
| Q1 2014 | -213,559 | Reduce 4.20% | 4.88 M | $52.50 |
| Q4 2013 | +1.4 M | Add 37.78% | 5.09 M | $47.71 |
| Q3 2013 | -2.05 M | Reduce 35.70% | 3.69 M | $42.75 |
| Q2 2013 | +5.75 M | Add 0.00% | 5.75 M | $36.06 |
Lee Ainslie's HCA Healthcare Investment FAQs
Lee Ainslie first purchased HCA Healthcare, Inc. (HCA) in Q2 2013, acquiring 5,745,514 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held HCA Healthcare, Inc. (HCA) for 38 quarters since Q2 2013.
Lee Ainslie's largest addition to HCA Healthcare, Inc. (HCA) was in Q2 2013, adding 5,745,514 shares worth $207.18 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 3,319 shares of HCA Healthcare, Inc. (HCA), valued at approximately $1.42 M.
As of the Q3 2026 filing, HCA Healthcare, Inc. (HCA) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in HCA Healthcare, Inc. (HCA) was 5,990,122 shares, as reported at the end of Q2 2014.